Fertility Services Market Will Generate New Growth Opportunities by 2027

Market Scope

Market Research Future (MRFR) confirms that the fertility services market 2020 held a value of USD 26,332.00 Million in 2019. MRFR also expects the market size to soar at a rate of 6.02% over the evaluation period of between 2020 and 2027.

Primary Boosters and Restraints  

The Centers for Disease Control and Prevention reveals in its latest study that almost 6% of all married women between the age of 15 and 44 years in the US are unable to conceive. Close to 12% of female population aged between 15 and 44 years in the country find it tough to get pregnant while studies also found that treatment of male infertility accounts for roughly 50% of the total cases. Sedentary or deskbound lifestyle, surging age of marriage, varicocele environmental factors, substance abuse, stress, genetic abnormalities, prostate cancer, obesity, and others are found to be the prime reasons for the escalating infertility rates across various countries.

Expanding population of working women has led to delay in family planning among couples. This factor is also working in favor of the global market. Surge in technological innovations in fertility treatments and the rising number of advanced services have raised the possibility of having children later in life for women. Costs of fertility services being covered by most of the insurance policies in various countries and the soaring number of healthcare facilities deploying modern techniques to improve the quality of their fertility services also foster the market size.

Segmental Review  

Fertility services market has been considered for underlying cause and treatment type.

With respect to underlying cause, the global market has been split into female infertility as well as male infertility. The male infertility segment can record the fastest growth rate of 6.23% in the upcoming period. The American Society for Reproductive medicines states that in close to 40% of couples, the male partner is generally infertile and among them, nearly 85% to 90% are provided treatment that are either drug-based or surgery-based.

Depending on treatment type, the global market caters to infertility drugs as well as assisted reproductive technology (ART). Between these, the ART segment took the top position with the highest valuation of USD 19,777.39 Million in the year 2019. The primary types of ART are artificial insemination (AI), ovulation induction (OI), preimplantation genetic diagnosis (PGD), in-vitro fertilization (IVF), donor conception, intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), surrogacy and more. These services witness substantial demand among couples and others, in view of the high success rate, lower risks and growing acceptance by the society.

Prominent Companies

Eminent firms in the fertility services market include Kitazato Cooperation, Irvine Scientific Company Inc., Monash IVF Group, Copper Surgical, Care Fertility, Vitrolife, Merck KGaA, Invo Bioscience, Cook Medical, Ferring B. V, and more.

Recent Updates

In December 2020, The Fertility Partners, a well-known fertility practice in Canada, confirmed its plan to expand its network by acquiring two clinics: Kelowna Regional Fertility Centre (KRFC) and Aurora Reproductive Care.

Article source: https://article-realm.com/article/Sports-Recreation/13109-Fertility-Services-Market-Will-Generate-New-Growth-Opportunities-by-2027.html